Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

12.27
+0.50004.25%
Post-market: 12.500.2300+1.87%19:54 EDT
Volume:421.79K
Turnover:5.16M
Market Cap:430.27M
PE:-102.25
High:12.51
Open:11.71
Low:11.60
Close:11.77
52wk High:13.25
52wk Low:5.65
Shares:35.07M
Float Shares:19.78M
Volume Ratio:1.79
T/O Rate:2.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1200
EPS(LYR):-0.3409
ROE:-18.58%
ROA:-1.16%
PB:10.14
PE(LYR):-36.00

Loading ...

Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Dec 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 30, 2024

Major Issues Report

Form 8-K - Current report
Oct 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 02, 2024

Major Issues Report

Form 8-K - Current report
Jun 27, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 25, 2024

Major Issues Report

Form 8-K - Current report
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]